Literature DB >> 13082472

Isoniazid in childhood tuberculosis.

G BOYD, T E ROY, A JOSIUKAS.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS/in infant and child

Mesh：

Substances：

Year:  1953        PMID： 13082472      PMCID： PMC1825197     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  The action of isoniazid (isonicotinic acid hydrazide) on intracellular tubercle bacilli.

Authors:  G B MACKANESS; N SMITH
Journal:  Am Rev Tuberc       Date:  1952-08

2.  Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid (rimifon, marsilid).

Authors:  W M BENSON; P L STEFKO; M D ROE
Journal:  Am Rev Tuberc       Date:  1952-04

3.  Antituberculous properties of hydrazines of isonicotinic acid (rimifon, marsilid).

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am Rev Tuberc       Date:  1952-04

4.  [Additional investigations in experimental chemotherapy of tuberculosis (neoteban)].

Authors:  G DOMAGK; H A OFFE; W SIEFKEN
Journal:  Dtsch Med Wochenschr       Date:  1952-05-02       Impact factor: 0.628

5.  Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.

Authors:  J BERNSTEIN; W A LOTT; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1952-04

6.  The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man.

Authors:  D F ELMENDORF; W U CAWTHON; C MUSCHENHEIM; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1952-04

7.  Isoniazid (isonicotinic acid hydrazide) in the treatment of miliary and meningeal tuberculosis.

Authors:  C M CLARK; D F ELMENDORF; W U CAWTHON; C MUSCHENHEIM; W MCDERMOTT
Journal:  Am Rev Tuberc       Date:  1952-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.